Table 2 Clinical and laboratory characteristics according to the monocyte-to-HDL ratio quartiles

Age(years)

57 ± 11

58 ± 11

60 ± 11

59 ± 11

Male sex [n (%)]

120(71.9%)

144(81.8%)

130(82.3%)

149(87.3%)

Smoking [n (%)]

69(41.3%)

84(47.5%)

82(51.9%)

80(46.8%)

Alcohol intake [n (%)]

54(32.3%)

62(35.0%)

69(43.7%)

66(38.6%)

Hypertension [n (%)]

74(44.3%)

82(46.3%)

80(50.6%)

87(50.9%)

Family history of CAD [n (%)]

34(20.4%)

38(21.5%)

34(21.5%)

39(22.8%)

Hypercholesterolemia[n (%)]

65(38.9%)

70(39.5%)

76(48.1%)

76(44.4%)

Diabetes [n (%)]

41(24.6%)

44(24.9%)

40(25.3%)

45(26.3%)

LVEF (%)

61 ± 7

62 ± 7

61 ± 7

61 ± 8

Gensini score

43 ± 43

45 ± 42

46 ± 37

52 ± 35

 SBP (mmHg)

130 ± 21

131 ± 24

135 ± 29

139 ± 29

 HR (bpm)

73 ± 9

74 ± 10

75 ± 11

76 ± 10

 WBC(×10⁹/l)

6.73 ± 2.14

7.36 ± 1.88

7.58 ± 2.43

8.28 ± 2.58

 MO(×10⁹/l)

0.36 ± 0.05

0.51 ± 0.18

0.54 ± 0.22

0.67 ± 0.23

 HB(× 10¹²/l)

141 ± 14

140 ± 16

139 ± 15

139 ± 14

 RDW(%)

13.21 ± 0.98

13.17 ± 0.79

13.15 ± 0.81

13.24 ± 0.20

 PLT(×10⁹/l)

212 ± 59

217 ± 72

211 ± 61

212 ± 61

 BUN(mmol/l)

5.49 ± 1.41

5.53 ± 1.63

5.40 ± 1.66

5.40 ± 1.70

 FBG(mmol/l)

6.15 ± 2.55

6.27 ± 2.51

6.54 ± 3.03

6.93 ± 2.91

 TG(mmol/l)

2.12 ± 1.25

1.87 ± 1.23

1.87 ± 1.15

2.37 ± 1.70

 TC(mmol/l)

4.53 ± 1.06

3.97 ± 1.09

3.93 ± 1.46

3.73 ± 1.07

 HDL-C(mmol/l)

2.89 ± 0.95

2.05 ± 0.78

1.31 ± 0.51

0.86 ± 0.30

 LDL-C(mmol/l)

1.27 ± 0.50

1.51 ± 0.98

1.97 ± 1.10

2.14 ± 0.97

 MHR

0.12 ± 0.05

0.25 ± 0.04

0.42 ± 0.06

0.82 ± 0.31

 IBIl(umol/l)

8.57 ± 4.43

9.21 ± 5.52

8.89 ± 5.22

8.26 ± 4.56

 DBIL(umol/l)

3.17 ± 2.02

3.51 ± 2.28

3.45 ± 2.59

3.10 ± 2.34

 Regular drugs taking

142(85%)

153(86.4%)

143(90.5%)

156(91.2%)

 Follow up time(m)

45 ± 26

45 ± 29

37 ± 25

31 ± 16

 ACM [n (%)]

1(0.6%)

1(0.6%)

4(2.5%)

8(4.7%)

 MACE [n (%)]

15(9%)

26(14.7%)

28(17.7%)

33(19.3%)